首页> 外文期刊>Molecular medicine reports >Identification of an lncRNA-miRNA-mRNA interaction mechanism in breast cancer based on bioinformatic analysis
【24h】

Identification of an lncRNA-miRNA-mRNA interaction mechanism in breast cancer based on bioinformatic analysis

机译:基于生物信息分析的乳腺癌LNCRNA-miRNA-mRNA相互作用机制的鉴定

获取原文
获取原文并翻译 | 示例
           

摘要

Non-coding RNAs serve important roles in regulating the expression of certain genes and are involved in the principal biological processes of breast cancer. The majority of studies have focused on defining the regulatory functions of long non-coding RNAs (lncRNAs) and microRNAs (miRNAs/miRs), and few studies have investigated how lncRNAs and miRNAs are transcriptionally regulated. In the present study, based on the breast invasive carcinoma dataset from The Cancer Genome Atlas at cBioPortal, and using a bioin-formatics computational approach, an lncRNA-miRNA-mRNA network was constructed. The network consisted of 601 nodes and 706 edges, which represented the complex web of regulatory effects between lncRNAs, miRNAs and target genes. The results of the present study demonstrated that miR-510 was the most potent miRNA controller and regulator of numerous target genes. In addition, it was observed that the lncRNAs PVT1, CCAT1 and linc00861 exhibited possible interactions with clinical biomarkers, including receptor tyrosine-protein kinase erbB-2, estrogen receptor and progesterone receptor, demonstrated using RNA-protein interaction prediction software. The network of lncRNA-miRNA-mRNA interactions will facilitate further experimental studies and may be used to refine biomarker predictions for developing novel therapeutic approaches in breast cancer.
机译:非编码RNA在调节某些基因的表达中提供重要作用,并参与乳腺癌的主要生物过程。大多数研究都集中于定义长期非编码RNA(LNCRNA)和MicroRNA(miRNA / mir)的调节功能,并且很少研究LNCRNA和MIRNA如何进行转录调节。在本研究中,基于Cbioportal的癌症基因组地图集的乳房侵入性癌数据集,并使用生物素 - 格式学计算方法,构建了LNCRNA-miRNA-mRNA网络。该网络由601个节点和706个边缘组成,其代表了LNCRNA,miRNA和靶基因之间的调节效应的复杂网。本研究的结果证明MIR-510是大量靶基因的最有效的miRNA控制器和调节因子。此外,观察到LNCRNA PVT1,CCAT1和LINC00861表现出与临床生物标志物的可能相互作用,包括使用RNA蛋白质相互作用预测软件证明的受体酪氨酸蛋白激酶ERBB-2,雌激素受体和孕激素受体。 LNCRNA-miRNA-mRNA相互作用的网络将促进进一步的实验研究,可用于改进用于在乳腺癌中发展新的治疗方法的生物标志物预测。

著录项

  • 来源
    《Molecular medicine reports》 |2017年第3期|共8页
  • 作者单位

    Zhejiang Sci Tech Univ Coll Life Sci 2 Xiasha Rd Hangzhou 310018 Zhejiang Peoples R China;

    Zhejiang Canc Hosp Dept Breast Canc Surg Hangzhou 310022 Zhejiang Peoples R China;

    Zhejiang Sci Tech Univ Coll Life Sci 2 Xiasha Rd Hangzhou 310018 Zhejiang Peoples R China;

    Zhejiang Canc Hosp Dept Breast Canc Surg Hangzhou 310022 Zhejiang Peoples R China;

    Zhejiang Sci Tech Univ Coll Life Sci 2 Xiasha Rd Hangzhou 310018 Zhejiang Peoples R China;

    Zhejiang Chinese Med Univ Clin Med Coll 2 Hangzhou 310053 Zhejiang Peoples R China;

    Zhejiang Canc Hosp Dept Breast Canc Surg Hangzhou 310022 Zhejiang Peoples R China;

    Zhejiang Sci Tech Univ Coll Life Sci 2 Xiasha Rd Hangzhou 310018 Zhejiang Peoples R China;

  • 收录信息
  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类 基础医学;
  • 关键词

    breast cancer; long non-coding RNA; microRNA; mRNA; bioinformatics;

    机译:乳腺癌;长期非编码RNA;microRNA;mRNA;生物信息学;

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号